AstraZeneca to appeal $215M verdict
Compliance Monitor, February 27, 2008
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
AstraZeneca plans to appeal a jury's decision to award $215 million to Alabama in a Medicaid pricing fraud lawsuit, according to CNNMoney.com.
In its February 21 decision, the jury said AstraZeneca must pay $40 million in compensatory damages and $175 million in punitive damages for alleged false and misleading reporting of drug prices reimbursed by the Alabama State Medicaid Agency.
AstraZeneca claims that the lawsuit was unfounded and errors that occurred during court proceedings should bring about the overturning of the verdict, according to CNNMoney.com.
AstraZeneca is one of 73 pharmaceutical companies sued by the Alabama Attorney General (AG) in 2005. Two other pharmaceutical companies settled with the AG.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Comments
0 comments on “AstraZeneca to appeal $215M verdict ”
Related Products
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Compliance Monitor
This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...
-
Medicare Weekly Update
Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...
-
Medicare Update for Physician Services
Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...
Most Popular
- Articles
-
- HIPAA Q&A: Level of encryption needed for email
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- Identify potential Medicaid RAC target areas
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Q&A: Acute respiratory failure diagnosis does not require intubation
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- Oxygen Cylinder Storage Requirements
- Q&A: Follow CMS' coding guidelines when using modifier -25
- Understand the spine to code back procedures correctly
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Searched